Informações:
Sinopse
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
Episódios
-
Episode 66: PORTICO I: One-Year Outcomes
17/04/2019 Duração: 03minC. Michael Gibson and Lars Sondergaard discuss 1-year outcomes in the PORTICO I trial.
-
Episode 65: SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose
03/04/2019 Duração: 04minDoes timing of an atorvastatin loading dose make a difference in PCI for ACS? C. Michael Gibson and Renato Lopes discuss.
-
Episode 64: Building a New Backbone Upon Which to Randomize Patients: PERT Registry
20/03/2019 Duração: 10minC. Michael Gibson, Kenneth Rosenfield, and Robert Lookstein discuss the way forward for PERT.
-
Episode 63: TRIVALVE: Evaluation of Edge-to-Edge Valve Repair
06/03/2019 Duração: 03minC. Michael Gibson and Jörg Hausleiter discuss the TRIVALVE trial.
-
Episode 62: BIONYX: A Randomized Trial
20/02/2019 Duração: 05minC. Michael Gibson and Clemens von Birgelen discuss the BIONYX randomized trial.
-
Episode 61: ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent
06/02/2019 Duração: 03minC. Michael Gibson and Pieter Stella discuss ReCre8, which evaluated a polymer-free DES in an all-comers population.
-
Episode 60: What Do You Get When You Combine Twitter and a Textbook? Tweetbook
23/01/2019 Duração: 03minWhat do you get when you combine Twitter and a textbook? C. Michael Gibson talks with Michael Savage and David Fischman.
-
Episode 59: IMPERIAL: A Randomized Trial of Drug-Eluting Stents
09/01/2019 Duração: 03minC. Michael Gibson talks to William Gray about IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions.
-
Episode 58: 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI
02/01/2019 Duração: 04minC. Michael Gibson speaks with Dominick Angiolillo about the 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI.
-
Episode 47: INTREPID
07/06/2018 Duração: 03minEarly results with a new device being developed for transcatheter MV replacement are promising, Paul Sorajja tells C. Michael Gibson.
-
Episode 46: DAPT-STEMI
18/05/2018 Duração: 05minC. Michael Gibson gets the details from DAPT-STEMI from Elvin Kedhi.
-
Episode 34: TRACER
08/01/2018 Duração: 04minTRACER: 6-Month Outcomes of Transcatheter MV Neochordal Repair in Patients With Severe Primary Mitral Regurgitation
-
Episode 35: TENDYNE Trial
08/01/2018 Duração: 03minDr. C. Michael Gibson talks to Dr. David W. M. Muller about TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation
-
Episode 33: DKCRUSH-V Trial
06/12/2017 Duração: 03minDr. C. Michael Gisbon talks to Dr. Shao-Liang Chen about the DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions.
-
Episode 31: PLATINUM DIVERSITY - Outcomes With Coronary Stenting in Women and Minorities
06/12/2017 Duração: 08minC. Michael Gibson reviews new registry results with Wayne Batchelor.
-
Episode 32: COLOR
30/11/2017 Duração: 08minListen to C. Michael Gibson in conversation with Giora Weisz. Color: A Multicenter Registry Looking at Lipid-Rich Plaque & 2-Year Outcomes After Stenting
-
Episode 30: PARTNER 2 Quality of Life
20/09/2017 Duração: 03minC. Michael Gibson discusses health-status benefits in intermediate-risk patients treated with surgical or transcatheter aortic valve replacement.
-
Episode 29: ILLUMENATE US
06/09/2017 Duração: 02minC. Michael Gibson sits down with Sean Lyden to discuss the results.
-
Episode 28: The AMULET OBSERVATIONAL STUDY
06/09/2017 Duração: 05minC. Michael Gibson speaks with David Hildick-Smith about left atrial closure devices for stroke prevention.
-
Episode 27: The WATCHMAN US Postapproval Study
15/08/2017 Duração: 05minC. Michael Gibson reviews the results with Vivek Reddy.